How to respond to signs of mild cognitive impairment and memory loss
Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...
Repetitive transcranial magnetic stimulation enhances tai chi chuan–linked benefits, study claims
Fujian University of Traditional Chinese Medicine in China has reported that repetitive transcranial magnetic stimulation ...
New criteria developed for appropriate use of cognitive impairment imaging tools
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
USC Study Exposes Hidden Culprit of Dementia in Brain’s Blood Vessels
A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...
Healio5d
Allosteric modulator nonsuperior to placebo in Parkinson’s disease
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
Severe Menopause Symptoms May Be Linked to Cognitive Decline—Here’s How to Protect Your Brain During This Time
New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...
PsyPost on MSN1d
Virtual reality cognitive training shows potential for treating adolescents with depression
A study examining the effects of virtual reality cognitive training on Chinese adolescents with mild to moderate depression ...
Monthly Prescribing Reference3d
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Healio4d
FDA grants biologics license application for monthly IV Leqembi
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...
WINK NEWS4d
Dementia risk factors unveiled
Eating healthy and staying active can help keep your brain sharp, but did you know your family's wealth may also affect your ...
HealthDay on MSN6d
Dementia Index Shows Validity for Predicting Age of Onset of MCI, Alzheimer Disease
The Florey Dementia Index (FDI) is valid for predicting the age of onset of mild cognitive impairment (MCI) and Alzhei ...